Lipid Sciences, Inc. Release: Presentation of In Vivo HDL Kinetic Data at the European Atherosclerosis Society 76th Congress Demonstrates Activation of Reverse Cholesterol Transport by Pre-Beta HDL in Selectively Delipidated Plasma

PLEASANTON, CA--(MARKET WIRE)--Jun 18, 2007 -- Lipid Sciences, Inc. (NasdaqGM:LIPD - News) -- At a meeting of the European Atherosclerosis Society, June 10-13, 2007 in Helsinki, Finland, Dr. Frank M. Sacks, made a presentation entitled, “Selective Delipidation of HDL in Plasma Produces Pre-Beta HDL Effective In Reverse Cholesterol Transport In Vivo In Monkeys.” This presentation was selected for the Late Breaking Session devoted to recent scientific advances. Dr. Sacks is a member of Lipid Sciences’ Scientific Advisory Board, and Professor of Cardiovascular Disease Prevention, Harvard School of Public Health, Professor of Medicine, Harvard Medical School, and Cardiovascular Division, Brigham and Women’s Hospital. The Abstract associated with this presentation is available on Lipid Sciences’ website at: www.lipidsciences.com, under the “Abstracts and Publications” heading.

MORE ON THIS TOPIC